128,95 €
128,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
64 °P sammeln
128,95 €
128,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
64 °P sammeln
Als Download kaufen
128,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
64 °P sammeln
Jetzt verschenken
128,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
64 °P sammeln
  • Format: ePub

Nearly 44 million people have Alzheimer's or related dementia worldwide, according to the Alzheimer's Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer's and other forms of dementia.First, readers are introduced to cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of…mehr

Produktbeschreibung
Nearly 44 million people have Alzheimer's or related dementia worldwide, according to the Alzheimer's Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer's and other forms of dementia.First, readers are introduced to cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to other symptoms, and the quality of life for those with Alzheimer's disease. In addition, the book discusses recent studies on memory dysfunction in advanced-stage Alzheimer's disease, in comparison to early-stage, including a chapter on the underlying factors in the transition from mild cognitive impairment to Alzheimer's diagnosis. Following this section, the book presents recent studies on the role of different cortical and subcortical structures in the development of various symptoms in Alzheimer's disease, as well as different neural biomarkers underlying the development and treatment of the disease. In the last section of the book, therapeutic aspects of Alzheimer's disease, focusing on behavioral and pharmacological treatments of sleep disorders, memory problems, and depression, are reviewed. The book aids readers in understanding the advances in research and care, making it a prime tool for all clinicians, psychologists, researchers, neurologists, and caregivers of dementia patients. - Reviews recent developments of cognitive and clinical studies - Covers factors underlying the transition from mild cognitive impairment to Alzheimer's disease - Discusses different neural biomarkers underlying the development and treatment of Alzheimer's disease - Provides a comparison of the effectiveness of various types of treatments

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Dr. Ahmed Moustafa is the Head of School of Psychology and Professor of Psychology and Computational Modeling at Bond University, Australia. He obtained his BSc in Mathematics and Computer Science at Cairo University, Egypt, and his PhD in Cognitive Science at the University of Lafayette, USA. Dr. Moustafa specializes in computational and neuropsychological studies of addiction, schizophrenia, Parkinson's disease, PTSD, depression, and Alzheimer's disease. He is the Editor-in-Chief of Discover Psychology (Springer) and has edited ten books, including Elsevier's Cognitive, Clinical, and Neural Aspects of Drug Addiction; The Psychology and Neuroscience of Impulsivity; Cognitive and Behavioral Dysfunction in Schizophrenia; Mental Health Effects of COVID-19; Alzheimer's Disease; Cybersecurity and Cognitive Science; Big Data in Psychiatry and Neurology; The Nature of Depression; and Social Cognition in Psychosis.
Rezensionen
"...covers many topics related to Alzheimer's disease, [including] relevant psychiatric illnesses associated with Alzheimer s, advances in research and technological contributions, and current treatments in people with dementia . [H]elps readers to understand how psychological research is being performed in Alzheimer's disease patients [and] does a great job in pointing out the difficulty in performing such research as dementia studies require more longitudinal collection of data [It] suggests possible solutions of using big database research methods to accelerate new findings in the field, useful to readers who design research studies in Alzheimer's diseases . [P]rovides disease pathology in relatively easy-to-understand phrases based on recent literature and discusses research models in which the disease can be studied best. Compared to other books that talk about the specific biochemical neuropathophysiology, [this] provides a much more general overview and psychological aspect of Alzheimer's disease." --©Doody s Review Service, 2023, Jane Lee, MD (Northwell Health)